Advancing the global cannabis industry
The foremost source of independent data, intelligence and strategy for the cannabis industry.
The Cannabis World Map
Click each continent to view key statistics on healthcare, market size and more
About UsLearn More
Prohibition Partners was founded in 2017 with a mission to open up the international cannabis industry through reliable data and intelligence.
Within two years, we have become the world’s leading provider of market insights and strategic consultancy for this emerging frontier. We firmly believe that data, insights and education will unlock the societal and commercial potential of cannabis.
Our research and content teams routinely share the latest legislative developments and key trends in the industry - information that is regularly cited by political leaders, investment banks and Fortune 500 companies.
Our consultancy team works with investors, operators and regulators to identify and execute opportunities across multiple jurisdictions. We advise our private clients on licensing, regulatory and business opportunities.
Our ServicesFind out more
Bespoke Research, Polling, Consumer Insight, Pricing, Market Forecasting.
Policy & Compliance, Regulatory Guidance, Supply / Demand.
Market Analysis / Entry, Business Development, Licensing, Partnerships.
ARE YOU READY TO EXPLORE OPPORTUNITY IN THE CANNABIS INDUSTRY?
News + InsightsView All
The global legal cannabis market is forecast to be worth up to US$103.9 billion by the year 2024, driven, in the most part, by the burgeoning international medicinal cannabis market,...
Key Insights from The Global Cannabis Report
Since legalising medical cannabis in 2017, Germany has become a leading power in the European cannabis industry and is set to become a behemoth in the global market in the...
The Germany Cannabis Report: Key Insights
Prohibition Partners releases The Global Cannabis Report, as Sadiq Khan calls for an evidence-based approach...
Germany’s ruling party discusses legalising adult-use cannabis, while Bernie Sanders details proposed cannabis legalisation policy....
Gibraltar permits cannabis prescriptions for four qualifying conditions, while France authorises medical cannabis pilot programme....
The medical cannabis sector in Germany is expected to be worth up to €7.7 billion...